| Collaborative diversity in a nanotechnology innovation system: Evidence from the EU Framework Programme K Pandza, T Wilkins, E Alfoldi Technovation 31, 476–489, 2011 | 107 | 2011 |
| Nano (Q) SAR: Challenges, pitfalls and perspectives R Tantra, C Oksel, T Puzyn, J Wang, KN Robinson, XZ Wang, CY Ma, ... Nanotoxicology 9 (5), 636-642, 2015 | 92 | 2015 |
| Characterization of Nanoparticle Batch-To-Batch Variability S Mülhopt, T Diabaté, Silvia, Wilkins, et al Nanomaterials 8 (5), 1-24, 2018 | 84 | 2018 |
| Characterization of Nanoparticle Batch-To-Batch Variability S Mulhopt, T Diabate, Silvia, Wilkins Nanomaterials DOI: 10.3390/nano8050311 8 (311), 24, 2018 | 84 | 2018 |
| (Q)SAR modelling of nanomaterial toxicity: A critical review C Oksel, CY Ma, JJ Liu, T Wilkins, XZ Wang Particuology 21, 1-19, 2015 | 73 | 2015 |
| Sensitive test for thyroid hormone autoantibodies in serum DJ Allan, F Murphy, CA Needham, N Barron, TA Wilkins, JEM Midgley The Lancet 320 (8302), 824, 1982 | 68 | 1982 |
| Comprehensive study of a thyroxin-analog-based assay for free thyroxin (" Amerlex FT4"). TA Wilkins, JE Midgley, Barron, N Clinical chemistry 31 (10), 1644-1653, 1985 | 60 | 1985 |
| Understanding the role and impact of poly (ethylene glycol)(PEG) on nanoparticle formulation: Implications for COVID-19 vaccines E Padín-González, P Lancaster, M Bottini, P Gasco, L Tran, B Fadeel, ... Frontiers in bioengineering and biotechnology 10, 882363, 2022 | 55 | 2022 |
| A comparison of free T4, and the ratio of total T4 to T4-binding globulin in serum through pregnancy AS Whitworth, JEM Midgley, TA Wilkins Clinical Endocrinology 17, 307-313, 1982 | 51 | 1982 |
| Electrochemical and morphological investigation of silver and zinc modified calcium phosphate bioceramic coatings on metallic implant materials M Furko, Y Jiang, TA Wilkins, C Balázsi Materials Science and Engineering: C 62, 249-259, 2016 | 46 | 2016 |
| Accurate and interpretable nanoSAR models from genetic programming-based decision tree construction approaches C Oksel, DA Winkler, CY Ma, T Wilkins, XZ Wang Nanotoxicology 10 (7), 1001-1012, 2016 | 43 | 2016 |
| New methods of free thyroid hormone assay TA Wilkins, JEM Midgley Bizollon, Ch.A. (ed.); 370 p; ISBN 0-444-80358-0; Worldcat; 1981; p. 215-234 …, 1981 | 42 | 1981 |
| EMERGNANO: A review of completed and near completed environment, health and safety research on nanomaterials and nanotechnology RJ Aitken, SM Hankin, B Ross, CL Tran, V Stone, TF Fernandes, ... Defra Project CB0409. Edinburgh, UK, Institute of Occupational Medicine, 2009 | 40 | 2009 |
| The direct estimation of free hormones by a simple equilibrium radioimmunoassay JEM Midgley, TA Wilkins Amersham: Radiochemical Centre, 1981 | 39 | 1981 |
| Application of isothermal titration calorimetry in evaluation of protein–nanoparticle interactions E Omanovic-Miklicanin, I Manfield, T Wilkins Journal of Thermal Analysis and Calorimetry 127, 605-613, 2017 | 35 | 2017 |
| Risk Management Framework for Nano-Biomaterials Used in Medical Devices and Advanced Therapy Medicinal Products E Giubilato Materials 13 (20), 4532, 2020 | 34 | 2020 |
| Treatment with heparin and results for free thyroxin: an in vivo or an in vitro effect? TA Wilkins, JE Midgley, AF Giles Clinical chemistry 28 (12), 2441-2443, 1982 | 33 | 1982 |
| Validity of analog free thyroxin immunoassays. Part II. JE Midgley, CR Moon, TA Wilkins Clinical chemistry 33 (12), 2145-2152, 1987 | 32 | 1987 |
| Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds GM Cree, TA Wilkins, R Monks, DP Nowotnik US Patent 4,426,453, 1984 | 31 | 1984 |
| EMERGNANO: A review of completed and near completed environment, health and safety research on nanomaterials and nanotechnology Defra Project CB0409 RJ Aitken, SM Hankin, B Ross, CL Tran, V Stone, TF Fernandes, ... Institute of Occupational Medicine Report TM/09/01, 2009 | 29 | 2009 |
Ceyda Oksel Karakus在 iyte.edu.tr 的电子邮件经过验证
